Harbour BioMed, a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, announced the appointment of Dr. Sanjay Keswani as Scientific Advisor in Neuroscience.
"We are delighted to welcome Dr. Keswani as our Scientific Advisor in Neuroscience," said Dr. Jingsong Wang, Founder, Chairman and CEO of Harbour BioMed. "His extensive expertise in neuroscience research and drug development, together with his proven track record of advancing innovative therapies through clinical development, will bring valuable insights to our scientific endeavors. We look forward to working closely with him as we continue to advance innovative therapies and address significant unmet medical needs in the neuroscience area."
"I am honored to join Harbour BioMed as a Scientific Advisor in Neuroscience," said Dr. Keswani. "Leveraging its industry-leading antibody technology platforms, Harbour BioMed has established a strong foundation in antibody discovery and engineering and built a differentiated product pipeline. I look forward to contributing my experience in neuroscience and drug development to support the Company's scientific endeavors and the advancement of innovative therapeutic approaches for patients."
